Relation of phosphodiesterase type 5 inhibitors and malignant melanoma: a meta-analysis and systematic review

Data on the association between using PDE5 inhibitors and malignant melanoma are conflicting. To estimate the relation of using PDE5 inhibitors with risk of malignant melanoma, Medline (Ovid) and Embase (Ovid) databases were searched up to February 2017, and a random effects model was used to calcul...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Jie, Shen, Yigen, Wang, Jiaoni, Xue, Yangjing, Liao, Lianming, Thapa, Saroj, Ji, Kangting
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Meta-Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5542281/
https://www.ncbi.nlm.nih.gov/pubmed/28515348
http://dx.doi.org/10.18632/oncotarget.17518

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5542281/
https://www.ncbi.nlm.nih.gov/pubmed/28515348
http://dx.doi.org/10.18632/oncotarget.17518

Ejemplares similares